Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2018

Mar 1, 2018

32227_dirs_2018-02-28_b48f24a2-b795-4555-998a-ae1b14e32fa0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-02-26

Reporting Person: SHOVLIN ROBERT J. (President, Clinical Services)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-26 Stock Option (Right to Buy) $8.03 A 288500 Acquired 2023-02-26 Common Stock (288500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6550 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $4.79 2019-10-13 Common Stock (300000) 300000 Direct
Stock Option (Right to Buy) $7.15 2021-04-20 Common Stock (200000) 200000 Direct
Stock Option (Right to Buy) $7.52 2022-04-28 Common Stock (200000) 200000 Direct
Restricted Stock $0.00 Common Stock (50000) 50000 Direct

Footnotes

F1: On October 13, 2014, Mr. Shovlin was granted an option to purchase 300,000 shares. The options have time based vesting. On the first anniversary of the option grant date 75,000 shares vest. Then beginning on the thirteenth (13th) month through the fourth anniversary of the option grant date 6,250 shares will vest on a monthly basis.

F2: On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F3: On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.

F5: Restricted stock will vest as follows; 16,666 will vest on May 25, 2018 and 16,667 will vest on May 25, 2019 and 2020.

F6: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.

F7: On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.